The Operating Theatre Journal - Journal - Page 9
THEATRE
JOBS
GUILDFORD
ENDOSCOPY & AMBULATORY CARE UNIT (ACU)
LEAD
£47,5K + BENEFITS
SENIOR SCRUB PRACTITIONER - £42K + BENEFITS
THEATRE PRACTITIONER - £36K + BENEFITS
NURSES OR ODP'S
ABERDEEN
THEATRE NURSE / ODP - UPTO £38,5K + BENEFITS
CONTACT
BANK THEATRE NURSE / ODP - UPTO £22 P.H +
SUZANNE
01304 200322
BENEFITS
SUZANNE@STERLINGCROSS.COM
Eitan Medical launches connected Avoset™ Infusion Platform
Avoset™ Infusion Platform is set to redefine post-acute care
Eitan Medical, a global leader in advanced
infusion therapy and drug delivery solutions
with reliable innovations that put patients at
the center of care, announced recently, the
launch of its new cutting-edge connected
infusion multi-therapy ambulatory infusion
system - Avoset™.
The connected Avoset™ Infusion System is
designed to transform post-acute care and
specialty infusion therapy with compact
and simplified technology that can monitor
infusion treatment data remotely, aiming to
enhance patient safety, and improve the user
experience.
Avoset Infusion System Video URL https://youtu.be/WRp3KO5D-r8
The Avoset™ Infusion Platform complements
the Sapphire Infusion portfolio and is
especially well positioned to address infusion
needs for therapies which require secure
medication reservoirs and long battery life at
low flow rates.
The Avoset Infusion Pump is MDR certified and
is currently available in selected European
countries. Eitan Medical is looking forward to
rolling out Avoset on an international scale in
2023.
Avoset Infusion System
(PRNewsfoto/Eitan Medical Ltd)
Shaul Eitan, GM and President of Eitan Medical,
Medication Delivery Solutions, commented:
“The recent spinout of Eitan Medical’s Sorrel
wearable injection device business, allows
Eitan Medical to focus on its core connected
infusion system solutions. The launch of Avoset
will transform infusion therapy in alternate
sites and is not only a triumph of innovation
and technology, but also a testament to the
dedication of Eitan Medical in providing the
best possible care for patients. It is a moment
of excitement and hope, as we look forward
to the transformative impact these solutions
will have on the lives of many patients and
caregivers around the world.”
Roger Massengale, Chief Commercial Officer,
stated: “We are thrilled to launch the Avoset
Infusion Platform, an innovative connected
ambulatory infusion pump that will transform
the way patients receive treatment in postacute care. We are confident that this new
infusion pump will make a positive impact
on the lives of patients and their caregivers,
Find out more 02921 680068 • e-mail admin@lawrand.com
Issue 392
providing them with the freedom and flexibility
to manage their treatment from the comfort
of their own homes. This confirms that Eitan
Medical is set for sustainable growth with a
focus on a strong innovation roadmap that will
redefine the drug delivery market.”
* Eitan Medical Ltd is legal manufacturer of the
Sapphire™ and Avoset™ Infusion Pumps.
https://eitanmedical.com/
https://eitanmedical.com/avoset-infusionpump/
THE
May
2023
9